Is Insulet Stock Outperforming the Dow?

Valued at a market cap of $18.5 billion, Insulet Corporation (PODD) develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The Massachusetts-based company focuses on improving the lives of people with diabetes and other conditions through its Omnipod delivery system.

Companies worth $10 billion or more are generally described as “large-cap” stocks, and Insulet fits right into that category with its market cap exceeding this threshold. The healthcare company is known for its wearable, disposable pod that delivers insulin for up to three days without the need for needles. It is also renowned for its tubeless system, which integrates with a continuous glucose monitor to manage blood sugar.